RxDoctor Payments Data

Rebecca Raffoul, PA

Physician Assistant · Tampa, FLNPI 1932621968

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.3% of the total across 43 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 14.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,436 and has fallen 91.0% since, to $129 in 2025.

$3,507in general payments, 2019–2025

Across 43 payments — averaging $81.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$514
  • Sanofi-aventis U.S. LLC$312
  • Genentech USA, Inc.$294
  • Jazz Pharmaceuticals Inc.$275
  • Incyte Corporation$250
  • Seagen Inc.$247
  • plus $2K from 17 others

What the payments were for

  • Food & beverage$3,41297%
  • Education$953%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,507 in reported general payments places this provider in the 85th percentile of 8,062 physician assistant providers in Florida.

See all physician assistant providers in Florida →

Medicare billing

Part B allowed, 2024
$5,852
Medicare patients
44
Services billed
74

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RevlimidLenalidomide24$397,540
Atovaquone25$12,460
ValacyclovirValacyclovir Hcl104$5,979
Ursodiol23$2,848
Acyclovir67$772
Clobetasol Propionate21$749
Famotidine38$433
Triamcinolone Acetonide22$374
Pantoprazole Sodium47$351
Ondansetron Hcl22$246
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim25$244
Allopurinol25$136
Gabapentin25$111
Omeprazole12$91

Paid to pharmacies, not to this prescriber.

Other physician assistant in Tampa

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →